Efzofitimod versus placebo in patients with pulmonary sarcoidosis (EFZO-FIT): a multicentre, rand...
October 27, 2026
Share
Efzofitimod versus placebo in patients with pulmonary sarcoidosis (EFZO-FIT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.